("
Admission of ordinary shares to the ISDX Growth Market
The Company announces that, with effect from
The Company's ordinary shares continue to be traded on AIM.
For further information please visit www.evocutis.com or contact the following:
|
|
|
David Lenigas / Donald Strang |
|
+44 (0) 20 7440 0640
|
James Caithie / Liam Murray
|
|
+44 (0) 20 7148 7900 |
Company Information
Evocutis is an investment company which is admitted to trading on AIM, focussed on the investment in, or acquisition of, companies or projects in the natural resources sector.
The Company has a 10% interest in
It also has a 2% interest in
Directors
The full names of the Directors of the Company and positions are as follows:
David Anthony Lenigas, Executive Chairman
Mr. Lenigas holds a Bachelor of Applied Science Degree in Mining Engineering. He served as Executive Chairman of London listed
Donald Ian George Layman Strang, Finance Director
Mr. Strang is a member of the
Hamish Hamlyn Harris, Non-Executive Director
Mr. Harris holds a Bachelor of Commerce degree and has worked in the investment banking industry for over 15 years in Singapore, Hong Kong and London, primarily in the area of market risk management. He has also run a privately owned private equity vehicle targeting acquisitions in agriculture in Eastern Europe in the last few years and is currently a director of
Sector Classification
Evocutis will be classified as a financial services company on ISDX.
Significant Shareholdings
Shareholder |
Number of Ordinary Shares held |
Percentage of |
HSBC Global Custody Nominee (UK) |
67,500,000 |
9.31% |
|
63,916,667 |
8.82% |
|
62,250,000 |
8.59% |
|
60,000,000 |
8.28% |
|
32,500,000 |
4.48% |
TD Direct Investing Nominees |
23,710,108 |
3.27% |
|
22,666,667 |
3.13% |
David Lenigas, Donald Strang and Hamish Harris each hold options over 10,000,000 ordinary shares in the Company at an exercise price of 0.22p; they do not hold any ordinary shares.
The percentage of securities in public hands is 65%. There are no restrictions on the transfer of Evocutis' securities.
Further Information
Evocutis was admitted to trading on AIM on
The Company will remain admitted to trading on AIM following admission to ISDX. Its ordinary shares are eligible for CREST settlement.
The Company is subject to the UK City Code on Takeovers and Mergers.
David Lenigas, Executive Chairman, commented: "We are seeking admission to ISDX as a means of further increasing liquidity and trading options for our shareholders and creating an additional platform on which to promote the Company's growth".
The directors of
COMPANY CONTACT DETAILS:
London
SW1Y 6DN
Telephone +44 (0)20 7440 0640
CORPORATE ADVISER AND CONTACT DETAILS:
James Caithie / Liam Murray / Richard Nash
61 Cheapside
London
EC2V 6AX
Telephone: +44 (0)20 7148 7900
This information is provided by RNS